Verition Fund Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-36,909
| Closed | -$119K | – | 2946 |
|
|
2025
Q1 | $119K | Sell |
36,909
-40,904
| -53% | -$132K | ﹤0.01% | 2472 |
|
|
2024
Q4 | $433K | Buy |
+77,813
| New | +$433K | ﹤0.01% | 1957 |
|
|
2024
Q3 | – | Sell |
-39,415
| Closed | -$827K | – | 2567 |
|
|
2024
Q2 | $827K | Buy |
+39,415
| New | +$827K | ﹤0.01% | 1248 |
|
|
2023
Q4 | – | Sell |
-167,137
| Closed | -$2.13M | – | 1986 |
|
|
2023
Q3 | $2.13M | Buy |
167,137
+94,428
| +130% | +$1.2M | 0.02% | 676 |
|
|
2023
Q2 | $1.31M | Buy |
+72,709
| New | +$1.31M | 0.02% | 724 |
|